Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: A randomised controlled trial

BMJ Open

Volumn 3, Issue 2, 2013, Pages

  Annane, Djillali ^a   Maxime, Virginie ^a   Faller, Jean Pierre ^b   Mezher, Chaouki ^c   Clec'h, Christophe ^d   Martel, Patricia ^e   Gonzales, Hélène ^f   Feissel, Marc ^b   Cohen, Yves ^d   Capellier, Gilles ^g   Gharbi, Miloud ^a   Nardi, Olivier ^a  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b Centre Hospitalier General   (France)

^c Centre Hospitalier André Boulloche   (France)

^d AVICENNE HOSPITAL   (France)

^e HÔPITAL AMBROISE PARÉ   (France)

^f CHU RANGUEIL   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ADULT; AGED; ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SINGLE BLIND PROCEDURE; SURVIVOR; TREATMENT DURATION;

EID: 84874991547     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002186     Document Type: Article

References (22)

1. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
2. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
3. Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomized trial. Lancet 2007;370:676-84. (Pubitemid 47299251)
4. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.
5. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-87. (Pubitemid 351397087)
6. Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010;303:341-8.
7. Schuetz P, Christ-Crain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:1059-66.
8. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomized controlled trial. Lancet 2010;375:463-74.
9. Jensen JU, Hein L, Lundgren B, et al. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med 2011;39:2048-58.
10. Matthaiou D, Ntani G, Kontogeorgi M, et al. Systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically-ill patients. An ESICM Systematic Review. Intens Care Med 2012;38:940-9.
11. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections. Lancet 2004;363:600-7.
12. Clećh C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006;34:102-7. (Pubitemid 43032386)
13. McCabe WA, Jackson GG. Gram negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110:847-55.
14. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591-7.
15. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPSII) based on a European/North American multicenter study. JAMA 1993;270:2957-63. (Pubitemid 24000804)
16. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intens Care Med 1996;22:707-10. (Pubitemid 26254283)
17. Gould AL. Interim analyses for monitoring clinical trials that do not materially affect the Type I error rate. Stat Med 1992;11:55-66.
18. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intens Care Med 1998;24:185-8. (Pubitemid 28190774)
19. Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intens Care Med 1998;24:680-4. (Pubitemid 28393399)
20. Castelli GP, Pognani C, Cita M, et al. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 2009;37:1845-9.
21. Chan YL, Tseng CP, Tsay PK, et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care 2004;8:R12-20.
22. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96. (Pubitemid 43810035)